Ptc Therapeutics (PTCT) Change in Acquisitions & Divestments (2013 - 2026)

Ptc Therapeutics' Change in Acquisitions & Divestments history runs 14 years deep, the most recent figure standing at $376.4 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 4130.65% year-over-year to $376.4 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 663.16% YoY), while the FY2025 annual figure was $783.9 million, up 1528.81% from the prior year.
• Change in Acquisitions & Divestments was $376.4 million for Q1 2026 at Ptc Therapeutics, down from $743.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $743.8 million in Q4 2025 to a low of -$242.7 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $96.3 million across 5 years, with a median of $11.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments surged 14300.0% in 2022, then sank 92.52% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $300.8 million in 2022, then tumbled by 97.4% to $7.8 million in 2023, then sank by 3199.73% to -$242.7 million in 2024, then jumped by 406.45% to $743.8 million in 2025, then tumbled by 49.4% to $376.4 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $376.4 million (Q1 2026), $743.8 million (Q4 2025), and $23.0 million (Q3 2025), per Business Quant data.